Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Number of holders
-
1,277
-
Total 13F shares, excl. options
-
490,550,647
-
Shares change
-
+7,878,242
-
Total reported value, excl. options
-
$45,304,945,713
-
Value change
-
+$713,718,504
-
Put/Call ratio
-
108%
-
Number of buys
-
555
-
Number of sells
-
-548
-
Price
-
$92.37
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2024
1,423 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q2 2024.
Edwards Lifesciences Corp - Common Stock (EW) has 1,277 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 490,550,647 shares
of 590,231,680 outstanding shares and own 83% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (53,576,014 shares), BlackRock Inc. (50,975,492 shares), STATE STREET CORP (26,009,095 shares), ALLIANCEBERNSTEIN L.P. (20,341,148 shares), Bank of New York Mellon Corp (19,782,909 shares), WELLINGTON MANAGEMENT GROUP LLP (16,922,602 shares), BROWN ADVISORY INC (16,552,147 shares), GEODE CAPITAL MANAGEMENT, LLC (13,236,229 shares), JPMORGAN CHASE & CO (8,678,917 shares), and NORGES BANK (8,537,780 shares).
This table shows the top 1,277 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.